TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
+32.14%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$543M
AUM Growth
+$543M
(+25%)
Cap. Flow
+$1.6M
Cap. Flow
% of AUM
0.3%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
3
Reduced
2
Closed
–
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$10.6M |
| 2 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$6.82M |
| 3 |
Puma Biotechnology
PBYI
|
$3.96M |
| 4 |
Prothena Corp
PRTA
|
$3.35M |
Top Sells
| 1 |
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
|
$21.3M |
| 2 |
Heron Therapeutics
HRTX
|
$1.82M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ODT
1
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $289M | 53.31% | 13,086,038 -961,212 | -7% | -$21.3M |
|
|
2
Heron Therapeutics
HRTX
$207M
| $140M | 25.87% | 5,744,096 -74,445 | -1% | -$1.82M |
|
3
Rocket Pharmaceuticals
RCKT
$354M
| $52M | 9.58% | 2,965,485 | – | – |
|
|
LJPC
4
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $31.8M | 5.85% | 4,938,893 +1,060,000 | +27% | +$6.82M |
|
|
5
Puma Biotechnology
PBYI
$254M
| $13.6M | 2.5% | 349,400 +102,000 | +41% | +$3.96M |
|
|
CELG
6
DELISTED
Celgene Corp
CELG
| $10.6M | 1.94% | +111,844 | New | +$10.6M |
|
|
7
Prothena Corp
PRTA
$441M
| $3.93M | 0.72% | 323,823 +276,213 | +580% | +$3.35M |
|
|
ISEE
8
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $846K | 0.16% | 600,000 | – | – |
|
9
Equillium
EQ
$62.2M
| $379K | 0.07% | 47,343 | – | – |
|